Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
Viking is evaluating both subcutaneous and oral formulations of VK2735 in clinical trials. Highlights from one poster presentation include new data from the
Benzinga via Yahoo
5 hours ago